Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Systems Biology Analysis for Ewing Sarcoma.
Petrizzelli M, Merlevede J, Zinovyev A. Petrizzelli M, et al. Among authors: merlevede j. Methods Mol Biol. 2021;2226:303-333. doi: 10.1007/978-1-0716-1020-6_23. Methods Mol Biol. 2021. PMID: 33326111
[No title available]
[No authors listed] [No authors listed] PMID: 35385067
[No title available]
[No authors listed] [No authors listed] PMID: 35462395
Transcriptomic and epigenetic profiling of 'diffuse midline gliomas, H3 K27M-mutant' discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location.
Castel D, Philippe C, Kergrohen T, Sill M, Merlevede J, Barret E, Puget S, Sainte-Rose C, Kramm CM, Jones C, Varlet P, Pfister SM, Grill J, Jones DTW, Debily MA. Castel D, et al. Among authors: merlevede j. Acta Neuropathol Commun. 2018 Nov 5;6(1):117. doi: 10.1186/s40478-018-0614-1. Acta Neuropathol Commun. 2018. PMID: 30396367 Free PMC article.
TP53 Pathway Alterations Drive Radioresistance in Diffuse Intrinsic Pontine Gliomas (DIPG).
Werbrouck C, Evangelista CCS, Lobón-Iglesias MJ, Barret E, Le Teuff G, Merlevede J, Brusini R, Kergrohen T, Mondini M, Bolle S, Varlet P, Beccaria K, Boddaert N, Puget S, Grill J, Debily MA, Castel D. Werbrouck C, et al. Among authors: merlevede j. Clin Cancer Res. 2019 Nov 15;25(22):6788-6800. doi: 10.1158/1078-0432.CCR-19-0126. Epub 2019 Sep 3. Clin Cancer Res. 2019. PMID: 31481512
Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents.
Merlevede J, Droin N, Qin T, Meldi K, Yoshida K, Morabito M, Chautard E, Auboeuf D, Fenaux P, Braun T, Itzykson R, de Botton S, Quesnel B, Commes T, Jourdan E, Vainchenker W, Bernard O, Pata-Merci N, Solier S, Gayevskiy V, Dinger ME, Cowley MJ, Selimoglu-Buet D, Meyer V, Artiguenave F, Deleuze JF, Preudhomme C, Stratton MR, Alexandrov LB, Padron E, Ogawa S, Koscielny S, Figueroa M, Solary E. Merlevede J, et al. Nat Commun. 2016 Feb 24;7:10767. doi: 10.1038/ncomms10767. Nat Commun. 2016. PMID: 26908133 Free PMC article.
12 results